By Meg Flippin Benzinga

DETROIT, MICHIGAN - April 23, 2025 (NEWMEDIAWIRE) - Lance Alstodt, CEO of BioRestorative Therapies (NASDAQ: BRTX), was recently a guest on Benzinga’s All-Access. 

BioRestorative Therapies is a regenerative medicine company that wants to alleviate chronic lower back pain, obesity and diabetes and is developing stem cell therapies to meet that end. The company’s flagship program, BRTX-100, which is in a phase 2 clinical trial, uses a patient’s stem cells to alleviate chronic back pain. Meanwhile, ThermoStem®  uses adipose-derived (brown fat) stem cells to generate new brown fat tissue to target metabolic diseases, including obesity and type 2 diabetes. Both are addressing unmet health needs that inflict pain and suffering on millions of people around the world. 

Watch the full interview here: 
https://www.youtube.com/watch?v=JkHcW6QMRlg

Featured image by Joyce Hankins on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.

This content was originally published on Benzinga. Read further disclosures here.

This contant was orignally distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies.